New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study

New disease-modifying treatments have recently been approved for 5q spinal muscular atrophy (SMA) and early treatment has been associated with a better clinical outcome. Accordingly, new-born screening (NBS) for SMA should be implemented to ensure early diagnosis of affected individuals. The aim of...

Full description

Bibliographic Details

Published in:	International Journal of Neonatal Screening
Main Authors:	Linda Gailite, Olga Sterna, Maija Konika, Aleksejs Isakovs, Jekaterina Isakova, Ieva Micule, Signe Setlere, Mikus Diriks, Madara Auzenbaha
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	spinal muscular atrophy <i>SMN1</i> dried blood spot screening new-born screening SMA 5q
Online Access:	https://www.mdpi.com/2409-515X/8/1/15